These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29484991)

  • 1. A New Investigational Perspective for Purines Against Glioblastoma Invasiveness.
    Giuliani P; Zuccarini M; Carluccio M; Ziberi S; Di Iorio P; Caciagli F; Ciccarelli R
    Curr Drug Targets; 2018; 19(16):1871-1881. PubMed ID: 29484991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem Cells.
    Ziberi S; Zuccarini M; Carluccio M; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Di Iorio P; Ciccarelli R
    Cells; 2019 Dec; 9(1):. PubMed ID: 31905754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme: a prospect towards the targeted therapy.
    Hasan S; Mahmud Z; Hossain M; Islam S
    Mol Biol Rep; 2024 Oct; 51(1):1069. PubMed ID: 39424705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRPX2 Enhances the Epithelial-Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Cells.
    Tang H; Zhao J; Zhang L; Zhao J; Zhuang Y; Liang P
    Cell Mol Neurobiol; 2016 Oct; 36(7):1067-76. PubMed ID: 26643178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitidine chloride suppresses epithelial-mesenchymal transition and stem cell-like properties in glioblastoma by regulating JAK2/STAT3 signaling.
    Jia M; Wang Y; Guo Y; Yu P; Sun Y; Song Y; Zhao L
    Cancer Med; 2021 May; 10(9):3113-3128. PubMed ID: 33788424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling.
    Song Y; Chen Y; Li Y; Lyu X; Cui J; Cheng Y; Zheng T; Zhao L; Zhao G
    Biomed Res Int; 2019; 2019():1321973. PubMed ID: 31119150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEO212, a conjugate of temozolomide and perillyl alcohol, blocks the endothelial-to-mesenchymal transition in tumor-associated brain endothelial cells in glioblastoma.
    Marín-Ramos NI; Jhaveri N; Thein TZ; Fayngor RA; Chen TC; Hofman FM
    Cancer Lett; 2019 Feb; 442():170-180. PubMed ID: 30392789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling.
    Chandrika G; Natesh K; Ranade D; Chugh A; Shastry P
    Sci Rep; 2016 Mar; 6():22455. PubMed ID: 26940200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.
    D'Alimonte I; Nargi E; Zuccarini M; Lanuti P; Di Iorio P; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Ciccarelli R
    Purinergic Signal; 2015 Sep; 11(3):331-46. PubMed ID: 25976165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
    Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT).
    Shi S; Qin Y; Chen D; Deng Y; Yin J; Liu S; Yu H; Huang H; Chen C; Wu Y; Zou D; Wang Z
    Eur J Pharmacol; 2022 Oct; 932():175176. PubMed ID: 35995211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling.
    Xu B; Jiang C; Han H; Liu H; Tang M; Liu L; Ji W; Lu X; Yang X; Zhang Y; Liu Y
    Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1296-307. PubMed ID: 26356761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation.
    Hassani Z; Saleh A; Turpault S; Khiati S; Morelle W; Vignon J; Hugnot JP; Uro-Coste E; Legrand P; Delaforge M; Loiseau S; Clarion L; Lecouvey M; Volle JN; Virieux D; Pirat JL; Duffau H; Bakalara N
    Mol Cancer Res; 2017 Oct; 15(10):1376-1387. PubMed ID: 28634226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
    Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
    Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSNK1D is associated with stemness and invasiveness in glioblastoma.
    Liu Y; He W; Guo Y; Qu S; Yao F; Liu J; Chai J; Yang Y; Xu T; Liu Y; Yang D; Jia Q; Li M
    Pathol Res Pract; 2022 Dec; 240():154187. PubMed ID: 36327821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR‑96 inhibits EMT by targeting AEG‑1 in glioblastoma cancer cells.
    Feng S; Yao J; Zhang Z; Zhang Y; Zhang Z; Liu J; Tan W; Sun C; Chen L; Yu X
    Mol Med Rep; 2018 Feb; 17(2):2964-2972. PubMed ID: 29257267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.